Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/2015 → 31/01/2018 |
Collaborative partners
- King's College London
- Queen Mary University of London (lead)
Funding
- MRC Medical Research Council: £12,069.40
Early Phase Clinical Trial repurposing ATRA as stromal targeting agent in a novel drug combination for pancreatic cancer (STAR-PAC)
- Sarker, Debashis (Primary Investigator)
Project: Research